Navigation Links
Surefire Medical, Inc.: Gene McGrevin Joins Surefire Medical's Board of Directors
Date:11/20/2012

WESTMINSTER, Colo., Nov. 20, 2012 /PRNewswire/ -- Surefire Medical, Inc., a developer of innovative high-efficiency infusion systems for the interventional radiology and interventional oncology markets, today announced the appointment of Gene McGrevin to its Board of Directors.

"Gene McGrevin is an excellent medical device strategist with a very strong background in sales, marketing and in running public companies.  As Surefire Medical transitions to full-scale commercialization in the U.S., Europe and Asia, Gene's addition to the Surefire Board is both timely and a great gain for the company," said Surefire Medical Board chairman Norman Weldon.

With 25 years of senior management positions in the medical industry at companies including Johnson & Johnson and Kimberly-Clark Corporation, Mr. McGrevin also was instrumental in the expansion and sale of several medical startups.  They include PetNet Pharmaceuticals (sold to Siemens), Microtek Medical Holdings (sold to EcoLabs), and Medivance (sold to C.R. Bard).  

"In my judgment Surefire Medical has the three key ingredients for success in the marketplace," McGrevin said.  "The company has innovative technology that physicians are quickly adopting due to its proven clinical impact on patient care.  It has strong IP.  And with higher embolization efficiency, Surefire Medical's infusion devices are cost-effective as well as clinically relevant."

Mr. McGrevin also serves on the Boards of the Yerkes Primate Center, Real Time Medical Data and HydroDynamics.

"We are delighted that Gene has joined the Board of Directors of Surefire Medical," said Jim Chomas, Chief Executive Officer.  "Gene's extensive experience in strategic market development brings additional valuable perspective to our Board.  I look forward to his contributions as we advance Surefire Medical's growth strategy."

Mr. McGrevin holds an MBA from the University of Pennsylvania's Wharton School.  He earned a BA in economics at the University of Pittsburgh.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop a platform of innovative infusion systems for the interventional radiology market.  Surefire's infusion catheters precisely deliver embolic agents through a novel expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow.  The Surefire Infusion System increases embolization efficiency, minimizes reflux and reduces damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Christopher Mennone Joins Surefire Medical Team As International Business Director
2. Surefire Medicals Infusion System For Embolization Procedures Receives CE Mark Approval
3. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
4. Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
5. Harwood Feffer LLP Announces Investigation of PSS World Medical, Inc.
6. Boston Scientific to Acquire BridgePoint Medical, Inc.
7. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
8. Haemonetics Provides Update on Hemerus Medical, LLC Acquisition
9. Solta Medical, Inc. Closes Public Offering of Common Stock
10. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
11. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
(Date:1/19/2017)... , January 19, 2017 ... European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement ... journal from touchONCOLOGY, an article by James ...
(Date:1/19/2017)...   Science Exchange , the leading marketplace ... the first five replication studies from the ... in eLife today. Despite intense scrutiny around reproducibility ... evaluation of reproducibility rates that may identify specific ... assessments of reproducibility, the results of this project ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... Michael and Betsy Brauser celebrated ... Institute. For Betsy, the clinical trial has been life-saving as she has been ... , Betsy Brauser was diagnosed with ovarian cancer in 2009. She underwent standard ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Mary Magdalene: ... the mysterious life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace ... denizen, who spent her career as an educator interacting with countless women who had ...
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... ... ... to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of Christmas. ... in Oklahoma City, and a devoted woman of faith. , “Becoming a parent changes ... back of my mind for years, but actually doing it might have been a while ...
(Date:1/20/2017)... ... ... “God's Miracle Man: Against All Odds”: an inspiring affirmation of God’s ... C. A. Tucker, son of Minister Delores Pinnock and a Jamaican native who lives ... , “While sitting up in bed, I felt a pounding headache. It was like ...
Breaking Medicine News(10 mins):